UK economic growth slows between April and June
Figures from the Office for National Statistics (ONS) showed growth in gross domestic product (GDP) slowed to 0.3% in the three months to the end of June, down from a rate of 0.7% in the first quarter.
Economists polled by Reuters, as well as the Bank of England, had forecast 0.1% growth in GDP for the April-June period.
Growth in the latest quarter was driven by increases of 0.4% in services and 1.2% in construction, while the production sector fell by 0.3%
ONS director of economic statistics Liz McKeown said: 'Growth slowed in the second quarter after a strong start to the year. The economy was weak across April and May, with some activity having been brought forward to February and March ahead of stamp duty and tariff changes, but then recovered strongly in June.
Read more: Rents set to rise as UK rental listings fall sharply, survey finds
'Across the second quarter as a whole growth was led by services, with computer programming, health and vehicle leasing growing. Construction also increased while production fell back slightly. Growth for the quarter was also boosted by updated source data for April, which while still showing a contraction, was better than initially estimated.
'Services also drove growth in June with scientific R&D, engineering and car sales all having a strong month. Within production, which recovered, manufacture of electronics performed especially well.'
Chancellor Rachel Reeves is gearing up for an autumn budget that economists have warned will require tax increases to fill a fiscal hole that exceeds £20bn.
Reeves warned there is 'more to do' to boost the economy after growth more than halved in the second quarter of the year.
The chancellor said: 'Today's economic figures are positive with a strong start to the year and continued growth in the second quarter. But there is more to do to deliver an economy that works for working people.
'I know that the British economy has the key ingredients for success but has felt stuck for too long.
'That is why we're investing to rebuild our national infrastructure, cutting back on red tape to get Britain building again and boosting the national minimum wage to make work pay. There's more to do and today's figures only fuel my ambition to deliver on our Plan for Change."
Monthly figures showed the economy returned to growth in June, expanding by 0.4%, surpassing predictions for 0.1% growth in a recovery from two months of negative output in April and May.
Read more: Best 0% purchase credit cards
Alice Haine, personal finance analyst at Bestinvest by Evelyn Partners, said: "For consumers, weaker growth in the second quarter is worrying. If earnings stagnate and redundancies ramp up — as suggested by the latest jobs data this week with unemployment remaining at a four-year high of 4.7%, vacancy levels falling and wage growth easing — many households could face renewed financial strain.
'A softening labour market, stubbornly high inflation, slowing wage increases and a higher tax burden present a troublesome combination for household budgets.
"While five interest rate cuts since August last year have offered some relief, the latest 25 basis-point reduction to 4% may not be reflected in lower borrowing costs across the board as some lenders remain cautious about future rate cut expectations amid niggling inflationary pressures. With food prices continuing to surge, the Bank of England has signalled that interest rates may need to remain elevated for longer as it expects consumer price inflation to peak of 4% in September.
"This will deliver a blow to households, with many still grappling with the lingering effects of the cost of living crisis."
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
MVV Energie Third Quarter 2025 Earnings: EPS: €0.36 (vs €0.38 in 3Q 2024)
Explore MVV Energie's Fair Values from the Community and select yours MVV Energie (ETR:MVV1) Third Quarter 2025 Results Key Financial Results Revenue: €1.35b (up 3.4% from 3Q 2024). Net income: €23.7m (down 4.4% from 3Q 2024). Profit margin: 1.7% (down from 1.9% in 3Q 2024). The decrease in margin was driven by higher expenses. EPS: €0.36 (down from €0.38 in 3Q 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period MVV Energie's share price is broadly unchanged from a week ago. Risk Analysis Before we wrap up, we've discovered 2 warning signs for MVV Energie (1 is significant!) that you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
8 minutes ago
- Yahoo
PolyPeptide Group First Half 2025 Earnings: Revenues Beat Expectations, EPS Lags
Explore PolyPeptide Group's Fair Values from the Community and select yours PolyPeptide Group (VTX:PPGN) First Half 2025 Results Key Financial Results Revenue: €167.1m (up 24% from 1H 2024). Net loss: €26.5m (loss widened by 133% from 1H 2024). €0.80 loss per share (further deteriorated from €0.35 loss in 1H 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period PolyPeptide Group Revenues Beat Expectations, EPS Falls Short Revenue exceeded analyst estimates by 12%. Earnings per share (EPS) missed analyst estimates by 40%. Looking ahead, revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Life Sciences industry in Switzerland. Performance of the Swiss Life Sciences industry. The company's shares are up 25% from a week ago. Risk Analysis Before we wrap up, we've discovered 1 warning sign for PolyPeptide Group that you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Fehler beim Abrufen der Daten Melden Sie sich an, um Ihr Portfolio aufzurufen. Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten
Yahoo
8 minutes ago
- Yahoo
Fastned B.V First Half 2025 Earnings: €0.94 loss per share (vs €0.59 loss in 1H 2024)
Explore Fastned B.V's Fair Values from the Community and select yours Fastned B.V (AMS:FAST) First Half 2025 Results Key Financial Results Revenue: €58.6m (up 55% from 1H 2024). Net loss: €18.3m (loss widened by 60% from 1H 2024). €0.94 loss per share (further deteriorated from €0.59 loss in 1H 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period Fastned B.V Earnings Insights Looking ahead, revenue is forecast to grow 30% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Specialty Retail industry in Europe. Performance of the market in the Netherlands. The company's shares are up 3.2% from a week ago. Risk Analysis Before you take the next step you should know about the 1 warning sign for Fastned B.V that we have uncovered. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data